Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants

Clinical trial NCT04506619 · TERMINATED

Trial details

NCT number: NCT04506619
Sponsor: Oak Hill Bio Ltd
Status: TERMINATED
Study type: OBSERVATIONAL

Retinopathy of Prematurity (ROP)Intraventricular Hemorrhage Bronchopulmonary Dysplasia Chronic Lung Disease of Prematurity

Start date: 2020-09-09
Primary completion: 2022-08-05
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.